Clinical trials
Observational Acidosis, Lactic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
| Changi General Hospital | 1 |
| Columbia University | 1 |
| Duke University | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Gulhane Training and Research Hospital | 1 |
| Hospices Civils de Lyon | 1 |
| National Center for Research Resources (NCRR) | 1 |
| National Institute of Environmental Health Sciences (NIEHS) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acidosis, Lactic | 17 |
| Diabetes Mellitus, Type 2 | 3 |
| Acidosis | 2 |
| Diabetes Mellitus | 2 |
| Hypoxia | 2 |
| MELAS Syndrome | 2 |
| Mitochondrial Myopathies | 2 |
| Sepsis | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Barth Syndrome | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.